Clinical Trial Update: Carbon Nanoparticles as Lymph Node Tracer in Rectal Cancer After Neoadjuvant Radiochemotherapy [NA]

View source ↗

Summary

Clinical trial evaluating carbon nanoparticles as a lymph node tracer for rectal cancer after neoadjuvant radiochemotherapy; current status is unknown for NCT03…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Carbon Nanoparticles (carbon nanoparticles)

Snippet

Sponsor: YE Yingjiang | Conditions: Rectal Cancer | NA | Status: UNKNOWN